Valuation check: 0R02.L's profit margin is -7605.93%, below the Healthcare sector average of 21.75%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
VivoSim Labs (0R02.L) currently reports a profit margin of -7605.93% as of September 2026. That compares with -1416.43% in the prior-year period — down 437.0% year over year. That is below the Healthcare sector average of 21.75%. Use the charts on this page to explore VivoSim Labs's profit margin history and peer comparisons.
VivoSim Labs's profit margin decreased from -1416.43% to -7605.93% — a 437.0% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
VivoSim Labs's profit margin of -7605.93% is lower than the Healthcare sector average of 21.75%. That is roughly 35074.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but VivoSim Labs's current -7605.93% should be judged against Healthcare norms (sector average: 21.75%) and against 0R02.L's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -7605.93%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.75%. From there, open related valuation or income-statement pages for VivoSim Labs, and consider following 0R02.L for alerts when major investors trade the stock.